News & Updates

New drug applications approved by US FDA as of 01 - 15 December 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Interventions that consist of mindfulness training, exercise, or both do not seem to produce any improvements in episodic memory or executive function at 6 months among older adults with subjective cognitive concerns, according to a study.

Weaker cognitive function appears to be more prevalent in older adults who are underweight and who engage in alcohol consumption and tobacco use, a recent India study has found.

In patients with advanced chronic kidney disease (CKD), discontinuing renin–angiotensin system (RAS) inhibitor therapy does not slow down decline in estimated glomerular filtration rate (eGFR), a recent trial showed.

Food appears to affect the pharmacokinetics of diazepam dosed via nasal spray, with absorption being markedly decreased and delayed, according to an open-label crossover study.

Restorative hearing devices may help stave off the risk of cognitive decline in patients with hearing loss, according to a systematic review and meta-analysis of 31 studies.

Among older adults, depressive symptoms aggravate the worsening of cognition, gait speed, and other comorbidities on disability, a recent study has found.